Steris | STE - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
3M USD 878M 119M 2026-03
Accuray USD 3.23M 6.56M 2024-12
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
CONMED USD 29.25M 24.98M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Ecolab USD 660.3M 57.4M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Fortive USD 193.9M 58.9M 2025-12
Getinge SEK 428M 1.54B 2025-03
Globus Medical USD 169.23M 25.24M 2025-12
Haemonetics USD 59.97M 8.69M 2025-12
Idexx Laboratories USD 355.44M 48.46M 2026-03
Inogen USD -6.06M 467K 2024-09
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 71.3M 3.6M 2026-03
Olympus JPY 27.08B 4.95B 2026-03
Orthofix International USD -2.19M 20.07M 2025-12
Owens Minor USD 35.71M 5.37M 2025-09
ResMed USD 496.15M 13.77M 2025-12
Steris USD 257.8M 66.6M 2025-12
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD 4.68M 29.82M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12